Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aeon Biotherapeutics is a Taiwan-based biotechnology company specializing in regenerative medicine and autologous cell therapies. Founded in 2014, the company develops and manufactures proprietary medical devices for the preparation of Platelet-Rich Plasma (PRP) and Bone Marrow Concentrate (BMC), including its flagship Aeon Acti-PRP and A-BMC systems. These products are designed to enhance the body's natural healing processes by concentrating growth factors and stem cells for applications in orthopedics, dermatology, gynecology, and wound care. Aeon Biotherapeutics holds regulatory approvals from the Taiwan FDA, US FDA, and CE mark, and its products are used globally to treat conditions such as osteoarthritis, bone defects, and thin endometrium.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aeon Biotherapeutics.